文献速递慢性肾脏病

美国住院儿童慢性肾脏病的医疗资源利用与死亡率

Inpatient Pediatric CKD Health Care Utilization and Mortality in the United States.
PubMed 文献 · Am J Kidney Dis · 2020-10-12

该研究基于美国儿童住院患者数据库的横断面调查,分析2006至2016年因慢性疾病住院的儿童。结果显示,伴有慢性肾脏病(CKD)的住院患儿住院时间更长、费用更高,且死亡风险增加。需进一步研究以了解其医疗需求。

要点

  • 住院患儿中CKD患病率约为3.9%。
  • CKD与住院时间延长29.9%、费用增加61.3%相关。
  • CKD患儿死亡风险比为1.51。

核心结论

  • 儿童CKD与住院时间延长、费用增加及死亡风险升高相关。

研究设计与样本

  • 横断面全国儿童出院调查,使用2006、2009、2012和2016年HCUP KID数据库。
  • 纳入年龄>28天至19岁、有慢性诊断的住院患儿。
  • 估计慢性病出院总数为6,524,745例。

主要发现

  • CKD患儿中位住院时间2.8天(IQR 1.4-6.0),无CKD患儿为1.8天(IQR 1.0-4.4),P<0.001。
  • CKD患儿中位住院费用8,755美元(IQR 4,563-18,345),无CKD患儿为5,016美元(IQR 2,860-10,109),P<0.001。
  • CKD与住院时间延长29.9%(95%CI 27.2%-32.6%)相关。
  • CKD与费用增加61.3%(95%CI 57.4%-65.4%)相关。
  • CKD与死亡风险升高相关,OR 1.51(95%CI 1.40-1.63)。

临床怎么用

  • 临床应关注住院CKD患儿的医疗资源需求,优化管理以降低住院负担。

局限性

  • 无法获取并调整再入院和实验室数据等混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The impact of chronic kidney disease (CKD) on inpatient health care use is unknown. This study aimed to describe the prevalence of pediatric CKD among children hospitalized in the United States and examine the association of CKD with hospital outcomes. STUDY DESIGN: Cross-sectional national survey of pediatric discharges. SETTING & PARTICIPANTS: Hospital discharges of children (aged>28 days to 19 years) with a chronic medical diagnosis included in the Healthcare Cost and Utilization Project Kids' Inpatient Database for 2006, 2009, 2012, and 2016. PREDICTOR: Presence of primary or coexisting CKD as identified by diagnosis codes. OUTCOMES: Length of stay (LOS), cost, and mortality. ANALYTICAL APPROACH: Multivariable analysis using Poisson, gamma, and logistic regressions were performed for LOS, cost, and mortality, respectively. RESULTS: A chronic medical condition was present in 6,524,745 estimated discharges during the study period and CKD was present among 3.9% of discharges (96.1% without CKD). Those with CKD had a longer LOS (median of 2.8 [IQR, 1.4-6.0] days compared with 1.8 [IQR, 1.0-4.4] days for those without a CKD diagnosis; P<0.001). Median cost was higher in the CKD group compared with the group without CKD, at $8,755 (IQR, $4,563-18,345) and $5,016 (IQR, $2,860-10,109) per hospitalization, respectively (P<0.001). Presence of CKD was associated with a longer LOS (29.9% [95% CI, 27.2%-32.6%] longer than those without CKD), higher cost (61.3% [95% CI, 57.4%-65.4%] greater than those without CKD), and higher risk for mortality (OR, 1.51 [95% CI, 1.40-1.63]). LIMITATIONS: Lack of access to and adjustment for confounders including patient readmission and laboratory data. CONCLUSIONS: Pediatric CKD was associated with longer LOS, higher costs, and higher risk for mortality compared with hospitalizations with other chronic illnesses. Further studies are needed to better understand the health care needs and delivery of care to hospitalized children with CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Modi ZJ, Waldo A, Selewski DT, et al. Inpatient Pediatric CKD Health Care Utilization and Mortality in the United States. Am J Kidney Dis. 2020. PMID: 33058964. doi:10.1053/j.ajkd.2020.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。